|
|
Article: Scientists in Hong Kong and the United States have developed an experimental H5N1 bird flu vaccine for people by piggybacking it on the well-tested vaccinia vaccine that was used successfully to eradicate smallpox.(RESEARCH & TECHNOLOGY)(Brief article)
- Article from:
- MondayMorning
- Article date:
- March 9, 2009
CopyrightCOPYRIGHT 2009 MedContent Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Scientists in Hong Kong and the United States have developed an experimental H5N1 bird flu vaccine for people by piggybacking it on the well-tested vaccinia vaccine that was used successfully to eradicate smallpox. Initial tests on mice showed the vaccine to be highly effective, they told a news conference in Hong Kong. "It produced a lot of (H5N1) antibodies and the speed of antibody response was far higher with this strategy than the Sanofi one," said Malik Peiris, a microbiologist and bird flu expert at the University of Hong Kong. Peiris was referring to Sanofi-Aventis SA's H5N1 bird flu vaccine for humans, which has been approved for use in the United States.
...
Related newspaper, magazine, and journal articles:
|
|
Article: Social support for two generations of new mothers in selected ...
Journal of Comparative Family Studies;
September 22, 2002 ;
700+ words
... ... three cultures: Korea, Hong Kong, and the United States. During the transition to ... significant to new mothers in the United States, which is currently experiencing ... indicated that new mothers in the United States commonly receive support ...
|
|